Your browser doesn't support javascript.
loading
Gold nano-particles (AuNPs) carrying miR-326 targets PDK1/AKT/c-myc axis in hepatocellular carcinoma.
Mo, Yichao; He, Longguang; Lai, Zeru; Wan, Zhiheng; Chen, Qinshou; Pan, Sibo; Li, Liangfu; Li, Dasheng; Huang, Junwei; Xue, Fan; Che, Siyao.
Afiliação
  • Mo Y; a Department of Hepatobiliary Surgery, Gaozhou People's Hospital , Gaozhou , China.
  • He L; a Department of Hepatobiliary Surgery, Gaozhou People's Hospital , Gaozhou , China.
  • Lai Z; a Department of Hepatobiliary Surgery, Gaozhou People's Hospital , Gaozhou , China.
  • Wan Z; b Department of General Surgery, The First Affiliated Hospital of BaoTou Medical University , Inner Mongolia , China.
  • Chen Q; a Department of Hepatobiliary Surgery, Gaozhou People's Hospital , Gaozhou , China.
  • Pan S; a Department of Hepatobiliary Surgery, Gaozhou People's Hospital , Gaozhou , China.
  • Li L; a Department of Hepatobiliary Surgery, Gaozhou People's Hospital , Gaozhou , China.
  • Li D; a Department of Hepatobiliary Surgery, Gaozhou People's Hospital , Gaozhou , China.
  • Huang J; a Department of Hepatobiliary Surgery, Gaozhou People's Hospital , Gaozhou , China.
  • Xue F; a Department of Hepatobiliary Surgery, Gaozhou People's Hospital , Gaozhou , China.
  • Che S; a Department of Hepatobiliary Surgery, Gaozhou People's Hospital , Gaozhou , China.
Artif Cells Nanomed Biotechnol ; 47(1): 2830-2837, 2019 Dec.
Article em En | MEDLINE | ID: mdl-31298047
ABSTRACT
Abnormal expression of microRNAs (miRNAs) contributes to tumour growth and invasion. MiR-326 expression often down-regulates in several kinds of cancer and low expression of miR-326 is linked with poor prognosis in cancer patients. In the present study, we aimed to explore the modulatory mechanism of miR-326 in hepatocellular carcinoma (HCC). miR-326 expression was significantly decreased in HCC cell lines and tissues. miR-326 decreased HCC cell growth by affecting cell-cycle progression and by promoting apoptosis. In addition, miR-326 inhibited HCC cell invasion by decreasing the EMT phenotype. We found that miR-326 functioned as a tumour suppressor by repressing its down-stream target PDK1. C-myc contributed to miR-326 down-regulation through binding at its promoter and inhibited its expression. Based on these results, we conducted a therapeutic experiment by using gold nano-particles (AuNPs) carrying miR-326. Restoration of miR-326 reduced tumour growth in vivo. Our findings suggest that miR-326 may be a candidate prognostic biomarker and a target for new therapies in HCC patients.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas c-myc / Carcinoma Hepatocelular / MicroRNAs / Proteínas Proto-Oncogênicas c-akt / Nanopartículas Metálicas / Piruvato Desidrogenase Quinase de Transferência de Acetil / Ouro Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Artif Cells Nanomed Biotechnol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas c-myc / Carcinoma Hepatocelular / MicroRNAs / Proteínas Proto-Oncogênicas c-akt / Nanopartículas Metálicas / Piruvato Desidrogenase Quinase de Transferência de Acetil / Ouro Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Artif Cells Nanomed Biotechnol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China